With the absolute quantification provided by Bio-Rad’s Droplet Digital™ PCR, the Vericheck ddPCR Empty-Full Capsid Kits require minimal volumes of either crude lysate or purified samples to deliver ...
Zacks.com on MSN21d
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right NowThe renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $9.57 billion. Bio-Rad’s earnings surpassed estimates in each of ...
Bio-Rad Laboratories, Inc.’s BIO solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback